Correlation Between Avenue Therapeutics and PsyBio Therapeutics

Can any of the company-specific risk be diversified away by investing in both Avenue Therapeutics and PsyBio Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Avenue Therapeutics and PsyBio Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Avenue Therapeutics and PsyBio Therapeutics Corp, you can compare the effects of market volatilities on Avenue Therapeutics and PsyBio Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Avenue Therapeutics with a short position of PsyBio Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Avenue Therapeutics and PsyBio Therapeutics.

Diversification Opportunities for Avenue Therapeutics and PsyBio Therapeutics

-0.01

Correlation Coefficient

Avenue Therapeutics  PsyBio Therapeutics

Good diversification

The 3 months correlation between Avenue and PsyBio is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding Avenue Therapeutics and PsyBio Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PsyBio Therapeutics Corp and Avenue Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Avenue Therapeutics are associated (or correlated) with PsyBio Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PsyBio Therapeutics Corp has no effect on the direction of Avenue Therapeutics i.e., Avenue Therapeutics and PsyBio Therapeutics go up and down completely randomly.

Pair Corralation between Avenue Therapeutics and PsyBio Therapeutics

Given the investment horizon of 90 days Avenue Therapeutics is expected to under-perform the PsyBio Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Avenue Therapeutics is 29.07 times less risky than PsyBio Therapeutics. The stock trades about -0.13 of its potential returns per unit of risk. The PsyBio Therapeutics Corp is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  0.01  in PsyBio Therapeutics Corp on September 17, 2024 and sell it today you would earn a total of  0.00  from holding PsyBio Therapeutics Corp or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.46%
Values	Daily Returns

Avenue Therapeutics  vs.  PsyBio Therapeutics Corp

Avenue Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Avenue Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

PsyBio Therapeutics Corp

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in PsyBio Therapeutics Corp are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak fundamental drivers, PsyBio Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Avenue Therapeutics and PsyBio Therapeutics

The main advantage of trading using opposite Avenue Therapeutics and PsyBio Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Avenue Therapeutics position performs unexpectedly, PsyBio Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PsyBio Therapeutics will offset losses from the drop in PsyBio Therapeutics' long position.

The idea behind Avenue Therapeutics and PsyBio Therapeutics Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.